The Department of Health and Human Services' Food and Drug Administration (FDA) awarded a $2.5 million single-award indefinite delivery, indefinite quantity (IDIQ) contract to Remel Inc., doing business as Thermo Fisher Scientific Remel Products, for the provision of various laboratory supplies compatible with Sensititre equipment. Remel is a foreign-owned, for-profit manufacturer of microbiology products that has extensive experience as both a prime contractor and subcontractor on numerous federal contracts. The IDIQ contract runs through March 2025 and allows the FDA to issue delivery orders for a range of Remel products, including supplies for the National Antimicrobial Resistance Monitoring System (NARMS) and the FDA's Center for Veterinary Medicine (CVM) programs. To date, the FDA has issued several delivery orders under this IDIQ, valued at approximately $375,000, for the procurement of Remel supplies to support the agency's regulatory science and public health missions at various locations in Maryland. The contracted laboratory supplies and diagnostic test kits will aid the FDA in evaluating antimicrobial susceptibility and monitoring antimicrobial resistance as part of its efforts to ensure the safety and effectiveness of medical products.
Generated 12/7/24, 9:04 AM